Shanghai United Imaging Healthcare Co., Ltd.

XSSC:688271 Stock Report

Market Cap: CN¥106.3b

Shanghai United Imaging Healthcare Valuation

Is 688271 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688271 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688271 (CN¥129.83) is trading above our estimate of fair value (CN¥102.49)

Significantly Below Fair Value: 688271 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688271?

Key metric: As 688271 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688271. This is calculated by dividing 688271's market cap by their current earnings.
What is 688271's PE Ratio?
PE Ratio67.2x
EarningsCN¥1.58b
Market CapCN¥106.32b

Price to Earnings Ratio vs Peers

How does 688271's PE Ratio compare to its peers?

The above table shows the PE ratio for 688271 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average64.4x
300760 Shenzhen Mindray Bio-Medical Electronics
25.4x14.7%CN¥314.5b
002223 Jiangsu Yuyue Medical Equipment & Supply
19.9x18.7%CN¥34.0b
688617 APT Medical
53.4x28.8%CN¥34.1b
688198 Beijing Balance Medical TechnologyLtd
158.9x41.1%CN¥16.3b
688271 Shanghai United Imaging Healthcare
67.2x32.3%CN¥106.3b

Price-To-Earnings vs Peers: 688271 is expensive based on its Price-To-Earnings Ratio (67.2x) compared to the peer average (63.6x).


Price to Earnings Ratio vs Industry

How does 688271's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688271 67.2xIndustry Avg. 34.5xNo. of Companies17PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688271 is expensive based on its Price-To-Earnings Ratio (67.2x) compared to the CN Medical Equipment industry average (34.9x).


Price to Earnings Ratio vs Fair Ratio

What is 688271's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688271 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio67.2x
Fair PE Ratio40.9x

Price-To-Earnings vs Fair Ratio: 688271 is expensive based on its Price-To-Earnings Ratio (67.2x) compared to the estimated Fair Price-To-Earnings Ratio (40.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688271 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥129.83
CN¥140.82
+8.5%
13.1%CN¥169.00CN¥110.40n/a10
Nov ’25CN¥123.80
CN¥136.12
+10.0%
10.6%CN¥162.81CN¥110.40n/a10
Oct ’25CN¥128.00
CN¥132.56
+3.6%
9.3%CN¥152.37CN¥110.40n/a10
Sep ’25CN¥105.71
CN¥148.80
+40.8%
10.1%CN¥160.39CN¥110.40n/a9
Aug ’25CN¥112.15
CN¥150.12
+33.9%
7.8%CN¥160.39CN¥122.36n/a9
Jul ’25CN¥107.48
CN¥155.50
+44.7%
8.7%CN¥185.00CN¥139.25n/a8
Jun ’25CN¥127.80
CN¥155.95
+22.0%
9.3%CN¥185.00CN¥139.25n/a7
May ’25CN¥132.56
CN¥153.61
+15.9%
11.3%CN¥185.00CN¥130.00n/a7
Apr ’25CN¥128.14
CN¥152.92
+19.3%
15.5%CN¥185.00CN¥117.54n/a6
Mar ’25CN¥138.50
CN¥146.51
+5.8%
14.0%CN¥175.00CN¥117.54n/a5
Feb ’25CN¥134.73
CN¥146.51
+8.7%
14.0%CN¥175.00CN¥117.54n/a5
Jan ’25CN¥137.01
CN¥134.05
-2.2%
13.6%CN¥160.00CN¥112.70n/a5
Dec ’24CN¥143.59
CN¥138.90
-3.3%
14.3%CN¥163.15CN¥112.70n/a6
Nov ’24CN¥116.00
CN¥140.57
+21.2%
13.9%CN¥163.15CN¥112.70CN¥123.806
Oct ’24CN¥104.09
CN¥153.60
+47.6%
16.3%CN¥192.90CN¥110.30CN¥128.006
Sep ’24n/a
CN¥155.97
0%
13.6%CN¥192.90CN¥124.50CN¥105.716
Aug ’24n/a
CN¥168.60
0%
14.3%CN¥219.20CN¥143.00CN¥112.156
Jul ’24n/a
CN¥173.94
0%
14.7%CN¥219.20CN¥143.00CN¥107.486
Jun ’24n/a
CN¥173.94
0%
14.7%CN¥219.20CN¥143.00CN¥127.806
May ’24n/a
CN¥181.30
0%
16.4%CN¥219.20CN¥143.00CN¥132.565
Apr ’24n/a
CN¥186.93
0%
18.9%CN¥225.43CN¥140.00CN¥128.145
Mar ’24n/a
CN¥184.13
0%
21.0%CN¥225.43CN¥136.00CN¥138.505
Feb ’24n/a
CN¥183.53
0%
21.4%CN¥225.43CN¥133.00CN¥134.735
Jan ’24n/a
CN¥184.07
0%
20.1%CN¥219.20CN¥133.00CN¥137.013
Dec ’23n/a
CN¥176.10
0%
24.5%CN¥219.20CN¥133.00CN¥143.592
Nov ’23n/a
CN¥176.10
0%
24.5%CN¥219.20CN¥133.00CN¥116.002

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies